Instrument overview

PACBPacific Biosciences of California

StockNasdaqAmerika Birleşik DevletleriHealth careEU retail: available
1/10
Balanced 1/101/10Balanced
Growth1/10
Balanced1/10
Income—/10

The Smart Score (1–10) describes how this instrument compares with its peers on published, rules-based measures of value, quality, trend, stability and dividend safety. It is not a forecast and not personal advice.

Compared with: Health care companies in USA (n = 211)

Current rating first published: · last recomputed · rating log

Factor scores

Value2 / 100
Quality10 / 100
Trend20 / 100
Stability18 / 100

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • Volatility (1 y)weighs on the score · percentile 8
  • Gross profit growth / assets (5 y)weighs on the score · percentile 20
  • Gross profit / assetsweighs on the score · percentile 3

Red flags and notes

  • Serious warning:Heavy dilution Share count growing more than 10 % a year over three years.
  • Caution:Cash burn Negative free cash flow in at least two of the last three years.
  • Caution:High leverage Net debt above 4× EBITDA or interest cover below 2×.
  • Caution:Negative equity Book equity is below zero.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

P/S
3,9
Market cap (EUR)
€552,5 Mn

Profitability and debt

Return on invested capital
−%22,1
Gross margin
%36,4

Dividends

Dividend yield
%0,00
Years of dividend growth
0

Returns and risk

1 day
−%2,9
1 month
+%47,4
1 year
+%25,2
Volatility, 1 yr
%92,6
Max drawdown, 1 yr
−%58,4
Beta
0,92

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

News and filings

  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

DateEventBalancedGrowth · IncomeWarningsPrice at publication
First rating 1/10 1 · — Serious warning:Heavy dilutionCaution:Cash burnCaution:High leverageCaution:Negative equity Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.